dipyridamole has been researched along with Intracranial Arteriosclerosis in 16 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Intracranial Arteriosclerosis: Vascular diseases characterized by thickening and hardening of the walls of ARTERIES inside the SKULL. There are three subtypes: (1) atherosclerosis with fatty deposits in the ARTERIAL INTIMA; (2) Monckeberg's sclerosis with calcium deposits in the media and (3) arteriolosclerosis involving the small caliber arteries. Clinical signs include HEADACHE; CONFUSION; transient blindness (AMAUROSIS FUGAX); speech impairment; and HEMIPARESIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The number of fatal and non fatal cerebral infarction was 31 in the P group, 17 in the ASA group, and 18 in the ASA + D group." | 2.65 | [The A.I.C.L.A. controlled cooperative trial. Secondary prevention of cerebral ischemic accidents due to atherosclerosis by aspirin and dipyridamole. 3: Results]. ( Bousser, MG; Eschwege, E; Haguenau, M; Lefauconnier, JM; Thibult, N; Touboul, D; Touboul, PJ, 1983) |
| "Nifedipine was demonstrated to potentiate relaxation effect of prostacyclin at the level of sarcolemmal calcium transport, while cavinton and dipyridamole had an analogous influence, redistributing calcium in the intracellular stores." | 1.27 | [Effect of prostacyclin on the cerebral vessels and its pharmacological modification]. ( Akopov, SE; Balaian, BG; Gabrielian, ES, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (81.25) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 1 (6.25) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Simard, T | 1 |
| Motazedian, P | 1 |
| Dhaliwal, S | 1 |
| Di Santo, P | 1 |
| Jung, RG | 1 |
| Ramirez, FD | 1 |
| Labinaz, A | 1 |
| Short, S | 1 |
| Parlow, S | 1 |
| Joseph, J | 1 |
| Rasheed, A | 1 |
| Rockley, M | 1 |
| Marbach, J | 1 |
| Domecq, MC | 1 |
| Russo, JJ | 1 |
| Chong, AY | 1 |
| Beanlands, RS | 1 |
| Hibbert, B | 1 |
| Gomez, CR | 1 |
| Qureshi, AI | 1 |
| Bousser, MG | 3 |
| Eschwege, E | 3 |
| Haguenau, M | 3 |
| Lefauconnier, JM | 3 |
| Thibult, N | 2 |
| Touboul, D | 3 |
| Touboul, PJ | 3 |
| Kistler, JP | 1 |
| Ropper, AH | 1 |
| Heros, RC | 1 |
| Dujovny, M | 1 |
| Kossovsky, N | 1 |
| Loubeau, JM | 1 |
| Nelson, D | 1 |
| McManus, G | 1 |
| De Marinis, M | 1 |
| Fieschi, C | 1 |
| Prencipe, M | 1 |
| Falchetti, R | 1 |
| Paolucci, S | 1 |
| Yatsu, FM | 1 |
| Paredero Del Bosque Martin, V | 1 |
| Eninia, GI | 2 |
| Purinia, IV | 1 |
| Timofeeva, TN | 1 |
| Borasi, G | 1 |
| Pallestrini, EA | 1 |
| Sperati, G | 1 |
| Gabrielian, ES | 1 |
| Akopov, SE | 1 |
| Balaian, BG | 1 |
| Smeltere, ES | 1 |
| Godlevska, MA | 1 |
| Logina, IP | 1 |
| Millikan, CH | 1 |
2 reviews available for dipyridamole and Intracranial Arteriosclerosis
| Article | Year |
|---|---|
Revisiting the Evidence for Dipyridamole in Reducing Restenosis: A Systematic Review and Meta-analysis.
Topics: Animals; Coronary Artery Disease; Coronary Restenosis; Dipyridamole; Endovascular Procedures; Humans | 2021 |
Therapy of ischemic cerebral vascular disease due to atherothrombosis. (2).
Topics: Anticoagulants; Arterial Occlusive Diseases; Aspirin; Auscultation; Basilar Artery; Blood Platelets; | 1984 |
3 trials available for dipyridamole and Intracranial Arteriosclerosis
11 other studies available for dipyridamole and Intracranial Arteriosclerosis
| Article | Year |
|---|---|
Medical treatment of patients with intracranial atherosclerotic disease.
Topics: Anticoagulants; Aspirin; Atherosclerosis; Brain Ischemia; Cilostazol; Clopidogrel; Dipyridamole; Emb | 2009 |
[Preliminary note on the therapeutic contribution of "RA 8" (Persantin) in neuropsychiatric manifestations of arteriosclerotic brain diseases].
Topics: Brain Diseases; Dipyridamole; Humans; Intracranial Arteriosclerosis | 1963 |
Scanning electron microscopic and X-ray energy spectrographic analysis of the inner surface of human atherosclerotic carotid plaques.
Topics: Aspirin; Carotid Artery Diseases; Carotid Artery, Internal; Dipyridamole; Female; Humans; Intracrani | 1981 |
Circulating platelet aggregates: a chronic platelet activation in patients with transient ischaemic attacks.
Topics: Aspirin; Cerebral Angiography; Dipyridamole; Humans; Intracranial Arteriosclerosis; Ischemic Attack, | 1980 |
For your stroke-prone patients: a guide to drug treatment.
Topics: Aged; Antihypertensive Agents; Aspirin; Brain Diseases; Cerebral Angiography; Cerebrovascular Disord | 1980 |
[Indications for surgical treatment and medical treatment of atherosclerosis].
Topics: Arteriosclerosis; Aspirin; Cholestyramine Resin; Clofibrate; Dextrothyroxine; Dipyridamole; Humans; | 1980 |
[The effect of kavinton, trental, sermion and kurantil on the blood flow rate in individual segments of the cerebral arteries].
Topics: Blood Flow Velocity; Cerebral Arteries; Chronic Disease; Dipyridamole; Drug Evaluation; Female; Huma | 1994 |
[The use of platelet aggregation-inhibiting drugs in central vestibular pathology caused by atherosclerotic vascular diseases].
Topics: Aspirin; Dipyridamole; Drug Evaluation; Humans; Intracranial Arteriosclerosis; Labyrinth Diseases; O | 1975 |
[Effect of prostacyclin on the cerebral vessels and its pharmacological modification].
Topics: Cadaver; Cerebral Arteries; Dipyridamole; Dose-Response Relationship, Drug; Drug Synergism; Epoprost | 1986 |
[Effect of antianginal agents on the cerebral circulatory indices in cerebral arteriosclerosis].
Topics: Adult; Amiodarone; Cerebrovascular Circulation; Chromonar; Dipyridamole; Drug Evaluation; Female; He | 1985 |
Address of the president-elect: the indication for various methods of treatment of occlusive cerebrovascular disease.
Topics: Anticoagulants; Aspirin; Blood Pressure; Cardiac Output; Carotid Arteries; Cerebral Angiography; Cer | 1973 |